首页|艾司氯胺酮通过NMDA受体促进小鼠成骨细胞增殖分化

艾司氯胺酮通过NMDA受体促进小鼠成骨细胞增殖分化

扫码查看
目的 探讨艾司氯胺酮对成骨细胞增殖分化的作用及其机制.方法 将从C57BL/6雄性小鼠中提取并诱导转化而成的成骨细胞置于不同浓度(0,6.25,12.5,25,50,100,200 μmol/L)的N-甲基-D-天冬氨酸(NMDA)中,采用CCK-8细胞毒性实验检测不同时间点(24,48,72,96 h)成骨细胞的活性,确定对增殖分化无毒性的NMDA浓度区间.将诱导分化的成骨细胞分为3组:对照组、艾司氯胺酮(Ket)组以及Ket+NMDA组,干预24,48,72 h采用荧光定量PCR(qPCR)法分别检测各组成骨细胞Runt相关转录因子2(Runx2)、成骨细胞特异性转录因子Osterix mRNA的表达情况;采用酶联免疫吸附法(ELISA)测定各组成骨细胞B淋巴细胞瘤-2基因(Bcl-2)、Bcl-2相关联的X基因(Bax)和脑源性神经营养因子(BDNF)相关蛋白的表达情况.结果CCK-8细胞毒性实验结果显示,在同一时间点,0~200 pmol/L的NMDA对成骨细胞活性的影响差异无统计学意义(P>0.05);在一定浓度下,NMDA干预不同时间对成骨细胞活性的影响差异无统计学意义(P>0.05).qPCR实验结果显示,与对照组相比,Ket组和Ket+NMDA组Runx2和Osterix表达均升高(P<0.01);与Ket组相比,Ket+NMDA组Runx2和Osterix表达下降(P<0.01).ELISA结果显示,与对照组相比,Ket组Bcl-2蛋白及BDNF蛋白的表达量升高(P<0.05),Bax蛋白的表达量下降(P<0.05);与Ket组相比,Ket+NMDA组Bcl-2蛋白及BDNF蛋白的表达量下降(P<0.05),Bax蛋白的表达量升高(P<0.05).结论 艾司氯胺酮可能通过阻断N-甲基-D-天冬氨酸受体(NMDAR)引起BDNF表达增加,进而促进抗凋亡蛋白的表达同时抑制凋亡蛋白的表达,最终对成骨细胞的增殖分化起到促进作用.
Esketamine promotes proliferation and differentiation of mouse osteoblasts through NMDA receptor
Objective To explore the effect and its mechanism of esketamine on the proliferation and differentiation of osteoblasts.Methods Osteoblasts were extracted and transformed from C57B 1/6 male mice.The toxicity of different concentrations(0,6.25,12.5,25,50,100,200 µmol/L)of N-methyl-D-aspartic acid(NMDA)for 24,48,72,96 h to osteoblasts was detected by cell counting kit-8(CCK-8)method to screen the appropriate concentration.The induced osteoblasts were divided into three groups:control group,esketamine(Ket)group and Ket+NMDA group.After 24,48,72 h intervention,the mRNA expression levels of Runt associated tran-scription factor 2(Runx2)and the osteoblast specific transcription factor Osterix in each group were detected by real-time fluorescence quantitative PCR(qPCR),and the expression levels of B-lymphoblastoma-2 gene(Bcl-2),Bcl-2-associated X gene(Bax)and brain-derived neurotrophic factor(BDNF)proteins in osteoblasts in each group were determined by enzyme-linked immunosorbent assay(ELISA).Results CCK-8 results showed that 0-200 µmol/L NMDA had no obvious toxicity to osteoblast proliferation at the same time point(P>0.05)and there was no significant difference in the activity of osteoblasts after NMDA intervention for different time(P>0.05).The qPCR results showed that the expression levels of Runx2 and Osterix in Ket group and Ket+NMDA group were higher than those in control group(P<0.01)and the expression levels of Runx2 and Osterix in Ket+NMDA group were lower than those in Ket group(P<0.01).ELISA results showed that the expression levels of Bcl-2 protein and BDNF protein in Ket group were higher than those in control group,while the expression level of Bax protein was lower(all P<0.05).Compared with Ket group,the expression levels of Bcl-2 protein and BDNF protein were decreased and Bax protein was increased in Ket+NMDA group(all P<0.05).Conclusion Esketamine may promote the proliferation and differentiation of mouse osteoblasts by blocking N-methyl-D-aspartate receptor(NMDAR),which increases BDNF expression,thus increasing the expression of anti-apoptotic proteins while inhibiting the expression of apoptotic proteins.

esketamineNMDARosteoblastsBcl-2BaxBDNF

郑马强、马智聪

展开 >

山西医科大学麻醉学院,太原 030001

山西医科大学第二医院麻醉科

艾司氯胺酮 NMDAR 成骨细胞 Bcl-2 Bax BDNF

山西省卫生健康委科研课题项目

2023023

2024

山西医科大学学报
山西医科大学

山西医科大学学报

CSTPCD
影响因子:0.931
ISSN:1007-6611
年,卷(期):2024.55(1)
  • 3